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Abstract
Background: The 11 human cysteine cathepsins are proteases mainly located in the endolysosomal compartment of all cells
and within the exocytosis pathways of some secretory cell types. Cathepsin H (Ctsh) has amino- and endopeptidase
activities. In vitro studies have demonstrated Ctsh involvement in the processing and secretion of the pulmonary surfactant
protein B (SP-B). Furthermore, Ctsh is highly expressed in the secretory organelles of alveolar type II pneumocytes where the
surfactant proteins are processed.
Methodology/Principal Findings: Hence, we generated Ctsh null mice by gene targeting in embryonic stem cells to
investigate the role of this protease in surfactant processing in vivo. The targeting construct contains a ß-galactosidase
(lacZ) reporter enabling the visualisation of Ctsh expression sites. Ctsh-deficiency was verified by northern blot, western
blot, and measurement of the Ctsh aminopeptidase activity. Ctsh
2/2 mice show no gross phenotype and their development
is normal without growth retardation. Broncho-alveolar lavage (BAL) from Ctsh
2/2 mice contained lower levels of SP-B
indicating reduced SP-B secretion. The BAL phospholipid concentration was not different in Ctsh
+/+ and Ctsh
2/2 mice, but
measurement of surface tension by pulsating bubble surfactometry revealed an impairment of the tension reducing
function of lung surfactant of Ctsh
2/2 mice.
Conclusions/Significance: We conclude that cathepsin H is involved in the SP-B production and reduced SP-B levels impair
the physical properties of the lung surfactant. However, Ctsh defiency does not reproduce the severe phenotype of SP-B
deficient mice. Hence, other proteases of the secretory pathway of type II pneumocytes, i.e. cathepsins C or E, are still able
to produce surfactant of sufficient quality in absence of Ctsh.
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Introduction
The family of papain-likecysteineproteases (Clan CA,C1 family)
consists of 11 members in humans, i.e. cathepsins B, C (J, dipeptidyl
peptidase I), F, H, K (O, O2), L, O, S, V (L2), W (lymphopain), and
X (P, Y, Z) [1]. All of these proteases have orthologous enzymes in
mice, only murine cathepsin L is homologous to both human
cathepsin L and human cathepsin L2(V) [2,3]. Hencethe analysis of
mouse models with targeted inactivation of cysteine cathepsins has
been widely used as rational approach to elucidate the in vivo
functions of these endosomal/lysosomal enzymes that can also
function outside the cell and as truncated protease variants in the
cytosol and the nucleus [4,5]. Specific cysteine cathepsins are
involved in precursor protein activation (including proenzymes and
prohormones), MHC-II-mediated antigen presentation, bone
remodelling, keratinocyte differentiation, hair cycle, reproduction,
and apoptosis [6]. They have also been implied to participate in
tumor progression and metastasis as well as in inflammatory
diseases, such as inflammatory rheumatoid arthritis, atherosclerosis,
and periodontitis, and are potential therapeutic targets [7].
Mature Ctsh is a 25 kDa endosomal/lysosomal enzyme that has
been activated by proteolytic removal of a 75 amino acid
propeptide from the Ctsh-zymogene. Cathepsin H and Cathepsin
B are unique among lysosomal cysteine proteases in that they are
both an exopeptidase and an endopeptidase [8,9,10]. The
structural basis of the aminopeptidase activity of Ctsh is provided
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26247by an eight residue residual portion of the propeptide, termed
mini-chain, that remains attached to the papain-like structure by a
disulfide link and provides its C-terminal Thr 83P carboxylic
group to capture the positively charged N-terminal amino group of
substrate proteins [11]. Removal of the mini-chain renders Ctsh a
complete endoproteinase [12,13]. However, it has been experi-
mentally shown that Ctsh is able to execute specific endoproteo-
lytic cleavage in native substrate proteins even in the presence of
the mini-chain [14].
Cathepsin H is considered a ubiquitously expressed protease;
however, strong expression has been reported in type II
pneumocytes [15]. Interestingly cathepsin C, a strict aminopep-
tidase, and Ctsh are the only cysteine-cathepsins found in the
secretory compartment of type II pneumocytes, and both proteases
have been shown to be functionally redundant [15,16]. The
lamellar and multivesicular bodies of these cells produce the lung
surfactant that is essential to reduce surface tension at the air-
liquid interface within the alveoli thus enabling breathing
mechanics and gas exchange. Pulmonary surfactant is composed
of phospholipids and proteins. These surfactant proteins (SP) are
either hydrophilic glycoproteins, i.e. SP-A and SP-D, or very
hydrophobic, i.e. SP-B and SP-C [17]. Notably, hereditary SP-B
deficiency results in neonatal onset surfactant deficiency and
respiratory failure in humans and mice [18]. The ,8.7 kDa SP-B
found in the air-space is generated from ProSP-B by several steps
of limited proteolysis within the secretory compartment of type II
pneumocytes. SP-B processing in type II pneumocytes is sensitive
to treatment with cysteine-cathepsin inhibitors and in vitro studies
proved that Ctsh is capable of processing SP-B [14,19]. Since a
mouse model for Ctsh-deficiency has not been available, we
generated a Ctsh knock-out mouse model in order to address the
role of Ctsh in SP-B processing and surfactant generation in vivo.
Results and Discussion
The murine cathepsin H (Ctsh) gene is located on mouse
chromosome 9 comprising 12 exons that span a genomic region of
22 kb. In the Ctsh gene targeting vector a b-geo cassette
containing IRES, lacZ-Reporter and a neomycine (neo) resistance
was flanked at the 59 end by approximately 2 kb Ctsh sequence
containing exon 4 and part of exon 5 and a DNA fragment at the
39 end consisting of intron 9 and exon 10 (Fig. 1A). Hence, by
homologous recombination in HM-1 mouse embryonic stem cells
part of exon 5 through part of intron 9 (including the active site
cysteine critical for enzyme activity in exon 6) of the Ctsh gene was
deleted and substituted by the b-geo cassette (Fig. 1A). Southern
blot using SacI restriction digest and probing with the external
5 `probe in genomic tail DNA confirmed correct homologous
recombination in the Ctsh locus by showing the expected 1.3 kb
band shift (Fig. 1B). These results were further confirmed by long
range PCR with external and internal primers (data not shown).
Northern blots with the 59 probe binding to exon 3 revealed
absence of the 1.6kb mRNA of Ctsh in liver and kidney of Ctsh
2/2
mice (Fig. 1C). In the Ctsh
2/2 samples a larger band correspond-
ing to the fusion transcript comprising the first 5 exons of Ctsh and
the IRES-LacZ reporter was detected (Fig. 1C). Taken together,
these results proof correct homologous recombination of the Ctsh
locus and the functionality of the targeting construct.
Accordingly, tissues of Ctsh
2/2 mice do not express the protease
as a protein (Fig. 2A) and show abolished proteolysis of the Ctsh-
specific aminopeptidase substrate H-Arg-AMC (Fig. 2B). Breeding
of heterozygous mice produced offspring with a statistical trend
(p=0.06) towards a reduced number of Ctsh null mice as
compared to the expected Mendelian ratio (Fig. 2C). However,
Ctsh deficient mice do not show a gross morphological phenotype.
Furthermore, Ctsh null mice show no impairment of reproductive
capacity or breeding behavior or nursing, and can be maintained
as homozygous mutant mouse line. Ctsh
2/2 and Ctsh
+/2 mice
developed indistinguishably from their wild-type littermates,
reached normal body weight (Fig. 2D), and lived without
phenotype for observation periods of up to two years. Histomor-
phology of kidney, liver, heart, brain, thymus, and spleen of Ctsh
2/2
mice did not show any signs of pathology (data not shown).
Cathepsin C (Ctsc; also named dipeptidylpeptidase 1) is an
aminopeptidase that has been shown to cooperate with Ctsh in
the processing of pro-granzyme B [16]. The cathepsin D-like
aspartic protease cathepsin E (Ctse) is another protease that might
compensate for the loss of Ctsh in the knock-out [20]. Hence we
determined the expression of both proteases as mRNA and protein
(Fig. 2E, F). Ctsc was not differently expressed or processed in lung
tissue samples from Ctsh
+/+ and Ctsh
2/2 mice. In general Ctse
expression in the lungs was at the limit of detection. Nevertheless,
we found an about 50% reduction of Ctse mRNA levels in Ctsh
2/2
(Fig. 2E). However, Western Blots for Ctse could not verify a major
difference in Ctse protein levels between Ctsh
+/+ and Ctsh
2/2 lungs
(Fig. 2F). Hence, our data exclude a compensatory upregulation of
cathepsinsC orE inthe lungsofCtsh deficientmice.However, both
proteases may be able to functionally compensate for the absence of
Ctsh simply by being able to sufficiently cleave most of the substrate
repertoire of Ctsh.
In the lung Ctsh has been shown to be specifically expressed in
type II pneumocytes [15]. Taking advantage of the lacZ reporter in
the Ctsh targeting construct a selective expression was detected in
distinct alveolar cells in lungs of Ctsh
+/2 mice with the typical
appearance of type II pneumocytes (Fig. 3A). In addition,
considerable lacZ expression was detected in the epithelia of small
airway bronchioles (Fig. 3B). Involvement of Ctsh in lung branching
morphogenesis has been recently reported [21], however, lung
morphology and histology was not altered in Ctsh-deficient mice
(Fig. 3C, D). Immunohistochemical detection of Ctsh confirmed the
absence of the protease in the lungs of Ctsh
2/2 mice (Fig. 3C,D),
while in wild-type mice the Ctsh staining pattern in lung tissue was
confined to specific alveolar cells, i.e. type II pneumocytes, and to
bronchioles (Fig. 3E,F). This provides evidence for the correct
function of the LacZ reporter that has been introduced to the Ctsh
locus by gene targeting (compare Fig. 1A).
Since type II pneumocytes produce and secrete surfactant we
analyzed the mRNA expression of the surfactant proteins A1 (SP-
A1), B (SP-B), and C (SP-C) (Fig. 4A). The mRNA levels of all
three surfactant proteins were not altered in the lungs of Ctsh
2/2
mice. Previous studies in vitro and in cultured human pneumocytes
demonstrated processing of SP-B by cysteine cathepsins and
identified Ctsh as the very likely candidate [14,19]. SP-B Western
Blots of lung tissue lysates did not reveal significantly altered levels
of SP-B precursor or SP-B processing intermediates in wild-type
and Ctsh-deficient lungs. However, broncho-alveolar lavage (BAL)
from Ctsh
2/2 mice contained lower levels of the fully processed 8.7
kDa SP-B (Fig. 4C). This result indicates reduced SP-B secretion
by the alveolar epithelia and suggests an impaired functional
quality of the lung surfactant of Ctsh knock-out mice. To further
investigate this, we evaluated the composition and the surface
activity of the surfactant which was isolated from the broncho-
alveolar fluid (BALF) of Ctsh
+/+ and Ctsh
2/2 mice. We found no
difference in the phospholipid concentration in the BALF (data not
shown), however, phospholipid concentration was adjusted to 1
mg/ml in all further experiments. Using a pulsating bubble
surfactometer the surface tension at the air–liquid interphase of
bubbles that had not been pulsating was 36.461.4 mN/m at 10 s
Phenotype of Cathepsin H Deficient Mice
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Ctsh
+/+ mice (Fig. 4D). The surface tension after 5 min of pulsation
was not significantly different at maximal bubble radius, but at
minimal radius surface tension was 11.061.7 mN/m and
18.760.9 mN/m for BALF from Ctsh
+/+ and Ctsh
2/2 mice,
respectively (Fig. 4E,F). Together these results indicate that the
reduced level of SP-B in the BALF of Ctsh-deficient mice impairs
the tension reducing function of lung surfactant.
In summary, homozygous deletion of Ctsh by gene targeting
does not result in a gross phenotype in the mice. However, in
agreement with previous studies Ctsh is involved in SP-B
processing and function of pulmonary surfactant derived from
Ctsh null mice is impaired. This biochemical phenotype is not a
complete phenocopy of inherited SP-B deficiency that results in
severe respiratory failure at birth. It is tempting to speculate
whether the slightly reduced frequency of Ctsh
2/2 offspring from
heterozygous mating may be caused by respiratory defects;
however, we were not able to observe (and to analyze) dead
newborns. It appears that the constitutive loss of Ctsh can be
compensated functionally (but not by compensatory upregulation)
by other cysteine or aspartic type proteases of type II
pneumocytes, such as cathepsin C and cathepsin E, respectively.
Using the newly developed Ctsh deficient mouse strain, a
cooperation of cathepsins H and C in progranzyme B processing
has been already established [16]. Hence, a network of proteases
may maintain the level of SP-B processing and secretion that is
needed to ensure sufficient surfactant and lung function in Ctsh
2/2
mice. However, these conclusions only hold true for the pathogen
free conditions in which the mice were kept during this study.
Cathepsin H knock-out mice may provide additional insights into
the functions of this protease when challenged. In this regard, it
has been shown recently that Ctsh
2/2 mice show less tumor
burden and cancer invasiveness when analyzed in the context of
the Rip1Tag2 model of pancreatic islet cancer [22]. Hence it will
be worthwhile to investigate the respiratory tract of this knock-out
mouse line when challenged by infections, sterile inflammations or
cancerous growth.
Materials and Methods
Ethics statement
The generation and phenotype analysis of cathepsin H deficient
mice in this study was performed in accordance to the German law
for animal protection (Tierschutzgesetz) as published on May 25,
1998. According to this law the animal work was reviewed and
approved by an ethics committee of the Regierungspra ¨sdium
(governmental regional board) Freiburg and given the project ID
‘G02/56 RP Freiburg’.
Generation of mice with targeted disruption of cathepsin
H (Ctsh)
Part of exon 5 through intron 9 of the Ctsh gene were replaced
by a targeting vector comprising IRES, lacZ-Reporter and a G418
resistance cassette (neo
r) using homologous recombination in
HM1-mouse embryonic stem cells (Fig. 1). G418-resistant HM1-
cell clones (129P2/OlaHsd background) were screened by
Southern blot analysis of genomic DNA, which was digested with
SacI and hybridized with the external probe (Fig. 1B). Mutated ES
cells were microinjected into blastocysts of C57BL/6N females.
The resulting chimeras were used to generate heterozygous
Figure 1. Targeted disruption of the cathepsin H (Ctsh) gene. (A) Scheme for the targeted disruption of mouse Ctsh gene by homologous
recombination. Exons are indicated by number. (B) Southern blot analysis of SacI-digested genomic DNA from mouse liver by the 59 external probe
denoted in panel A. Expected fragment sizes are 5.5 kb for wild-type and 6.8 kb for mutant Ctsh alleles. (C) Northern blots from liver and kidney
samples of Ctsh
+/+ and Ctsh
2/2 mice. The Ctsh 59 probe detects the genuine 1.6 kb mouse Ctsh transcript in the Ctsh
+/+ samples. *Denotes an
enlarged transcript in Ctsh
2/2 consisting of Ctsh exons 1–5 plus lacZ reporter.
doi:10.1371/journal.pone.0026247.g001
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PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26247Figure 2. Cathepsin expression and gross phenotype of Ctsh-deficient mice. (A) Western blotsfor Ctsh detection inlungs andliver ofCtsh
+/+
and Ctsh
2/2 mice. (B) Detection of ‘‘acidic’’ aminopeptidase activity at pH 6.0 in lungs, livers and kidneys of f Ctsh
+/+ and Ctsh
2/2 mice (n=3). (C)
Observed and expected genotype frequencies of litters from Ctsh
+/2 x Ctsh
+/2 matings. (D) Weight gain of female littermates from heterozygous
matings (n=5 per genotype). (E) mRNA expression of cathepsin C (Ctsc) and cathepsin E (Ctse) measured by quantitative ‘real-time’ RT-PCR in lungs
of Ctsh
+/+ and Ctsh
2/2 mice (n=5 per group). (F) Cathepsin C (Ctsc) and cathepsin E (Ctse) detected by Western blotting in Ctsh
+/+ and Ctsh
2/2 lung
lysates.
doi:10.1371/journal.pone.0026247.g002
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genetic background. Mice were backcrossed onto the C57BL/6N
for 10 generations. Mice were bred and maintained under specific-
pathogen-free conditions.
Genotyping
Routine genotyping of Ctsh deficient mice is performed on
genomic DNA by PCR. The primer pair Ctsh-fw / Ctsh-rev
amplifies 426 base pairs of the wild-type allele that is deleted in the
mutant: Ctsh-fw: 59 TAA-ATG-GGC-TAG-TGA-ATG-CTG-
ACG 39; Ctsh-rev: 59 TGA-ATC-TGG-AGT-TTG-GAG-GGT-
AGT 39. The primer neo
r anneals in the 3 `end of the G418
resistance cassette while primer Ctsh intron 9-rev is located in the
not deleted part of intron 9. Thus this primer pair will amplify the
mutated alleles as an 205 bp fragment : neo
r 59 ATC-GCC-TTC-
TAT-CGC-CTT-CTT 3 `; Ctsh intron 9-rev: 59 CAC-CCC-ATG-
ATT-CCT-TCC-TG 3 `. PCR annealing temperature of 56uC for
30 seconds and elongation at 72uC for one minute are
recommended for a total of up to 35 cycles.
qRT PCR
Total RNA was isolated from frozen lung tissue samples with
RNAeasy Mini kit (Qiagen) and reverse transcribed using iSript
cDNA Synthesis kit (Bio-Rad). Transcripts were quantified using
Platinum SyBRH Green qPCR SuperMix (Invitrogen) and the
following primer pairs: Ctsc, 59 ACC TGG GTG TTC CAG
GTG GGC CC39 (fw.) and 59GCC CGG AAT TGC CCA GCT
CGT CG39 (rev.); Ctse, 59CAG TCC GAC ACA TAC ACG39
and 59TGC CCT GGC TCC TTG AC39 (rev.); SP-A1, 59TGC
AGG CTC TGT GTG CGG GGA TCT39 (fw.) and 59CAG
GGA TCC CAG GGC TTC CGG CA (rev); SP-B, 59AGC AAC
AGC TCC CCA TTC CCC TGC C39 (fw.) and 59CCA CCA
CCA GGG GTA CCA CGT GGC39 (rev.); SP-C, 59TGA CTA
CCA GCG GCT CCT GAC GGC39 (fw.) and 59GTG GGT
GTG GAG GGC TTG GCC TGG39 (rev.).
Northern blot
For detection of Ctsh mRNA by Northern blots, total RNA of
kidney and liver from adult mice was prepared according to a
standard protocol[23]. Subsequently 5 mg total RNAwasseparated
ina formaldehyde agarose geland processedasdescribed previously
[24]. Filters were hybridized with [a-32P]dCTP labelled probes of
Ctsh exon 3 and a cDNA fragment of mouse b-actin.
Enzymatic activity
Ctsh aminopeptidase activity was measured by degradation of
synthetic substrate H-Arg-4-Methyl-Coumarin-7-Amid (AMC). A
crude organelle fraction was obtained by differential centrifugation
Figure 3. Cathepsin H expression in the lung. (A) Expression of the lacZ reporter (blue staining) in Ctsh
+/2 mice as indication for Ctsh
transcription in distinct alveolar cells, i.e. type II pneumocytes (arrows heads), and (B) in small airway bronchioles (indicated by *). (C–D) Histology
and absent immunohistochemical detection of Ctsh in Ctsh
2/2 lungs. (E–F) Immunohistochemical detection of Ctsh in lungs of wild-type mice
confirms the expression of Ctsh in distinct pneumocytes and bronchiolar epithelium (indicated by *). Scale bars are 50 mm.
doi:10.1371/journal.pone.0026247.g003
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PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26247Figure 4. Cathepsin H function in production of lung surfactant proteins. (A) mRNA expression of surfactant proteins A1, B, and C measured
by quantitative ‘real-time’ RT-PCR in lungs of Ctsh
+/+ and Ctsh
2/2 mice (n=5 per group). (B) Detection of surfactant protein B (SP-B) in lung tissue
lysates (C) Western blot detection of SP-B in broncho-alveolar lavage (BAL) of Ctsh
+/+ and Ctsh
2/2 mice of 2 genetic backgrounds (129P2/OlaHsd and
C57BL/6N). The lysosomal membrane associated protein 2a (Lamp 2a) is present at the limiting membrane of lamellar bodies [27,28] and serves as
loading control independent of the surfactant proteins. (D–F) Surface activity of BAL fluid measured by pulsating bubble surfactometry (n=6–10).
doi:10.1371/journal.pone.0026247.g004
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ultra-sound in 50 mM of phosphate buffer (pH 6.0) containing 2.5
mM EDTA/ 2.5 mM DTT. H-Arg-AMC substrate (50 mM) was
added and release of fluorescent AMC (excitation 359 nm/
emission 540 nm) was monitored for 30 min at 37uC.
Western blot
Aliquots of the BALF (3 mg protein) or crude organelle fractions
(10 mg protein) were separated using 4-12% NuPageH Bis-Tris Gel
(Novex / Invitrogen, Carlsbad, USA) and MES buffer and blotted
to nitrocellulose membranes (Hybond ECL, Amersham Pharma-
cia Biotech, Little Chalfont, U.K.). The membranes were blocked
using non-fat dry milk (16 h, RT) and incubated with affinity
purified SP-B antiserum (kindly donated by Dr. J.A. Whitsett
(Cincinatti, OH)) or with.affinity purified cathepsin H antiserum
(kindly donated by Dr. E. Weber (Halle, Germany). The
immunoreaction was detected using polyclonal antisera directed
against rabbit or mouse IgG conjugated to horse radish peroxidase
and ECT (Novex / Invitrogen, Carlsbad, USA) as substrate.
In order to detect proSP-B frozen lung tissue samples were lysed
with TritonX lysis buffer (0.2% TritonX-100 in PBS). To detect
Ctsc and Ctse sodium acetate lysis buffer (100mM sodium acetate,
1mM EDTA, 0.05% Brij) was used. Proteins (10 mg) were
separated on 15% Bis-Tris gels and blotted to PVDF membranes
(Amersham). Membranes were blocked with 3% powdered milk
(for Ctsc, and Ctse) or 4% BSA (for SP-B). For immunodetection
membranes were probed with a 1:500 dilution of anti-mouse Ctsc
or anti-mouse Ctse antibody (R&D Systems AF1034, AF1130), or
anti-SP-B antibody (Millipore ABS21) and HRP conjugated anti-
goat (Sigma A5420) or anti-rabbit (Biorad 172-1019) secondary
antibodies.
Histology, Immunohistochemistry and b-galactosidase
(LacZ) staining
The Lac-Z reporter in the gene targeting construct provides
direct visualization target gene expression in tissues of gene
targeted mice. Fixation of the lungs was by lacZ-fixation solution
(0.4 ml 25% glutaraldehyde; 1.25ml 0.2M EGTA (pH 7.3); 5.0ml
1M MgCl2; 43.0 ml PBS) for 2h at 4uC. After 3x5 min PBS
washes and the samples were incubation in 20% sucrose in PBS
for 16 h at 4uC. The dehydrated tissues were embedded in OCT
(water soluble glycol’s and resins compound) by freezing in liquid
nitrogen. Cryosections (10 mm tickness) were post-fixed in 0.2%
glutaraldehyde / PBS for 10 min at room temperature followed
3x5min washes in lacZ-buffer composed of 0.5ml 1M MgCl2; 0.25
ml 10% sodium-deoxycholate; 2.5ml 2% Nonidet-P40; 265 ml
PBS. Detection of lacZ (i.e. b-galactosidase activity) section was
achieved by an overnight incubation in 87.5ml lacZ buffer
supplemented with 2.5 ml X-gal (i.e. bromo-chloro-indolyl-
galacto-pyranoside dissolved at 40mg/ml in DMSO) and 5 ml
0.1M potassium-ferricyanide at 37uC in the dark. The stained
sections were observed und photographed under digital optical
microscope.
For immunodetecton of Ctsh, paraffin embedded lung tissue
sections were incubated with a 1:40 dilution of anti- mouse Ctsh
antibody (R&D Systems AF1013) followed by detection with the
Vectastain Elite ABC kit (Vector Laboratories) and 3,3-DAB and
nuclear staining with hematoxylin.
Broncho-alveolar lavage (BAL)
BAL was performed by cannulating the trachea and infusing the
lungs with 260.8 ml cold sterile PBS/2 mM EDTA. The broncho-
alveolar lavage fluid (BALF) was retrieved by gentle aspiration.
The BALF was pooled and the cells were transferred to a
microscope slide by cytospin (10 min, 400 xg). The supernatants
were collected and frozen at –80uC.
Surfactant aggregate separation and evaluation with
pulsating bubble surfactometer
The cell-free supernatant was centrifuged at 48,000 xg for 60
min at 4uC to pellet large surfactant aggregates (LA). The
supernatant, containing small surfactant aggregates (SA), was
removed and the LA pellet was resuspended in Ringer’s solution.
The phospholipid contents of the LA pellets and the SA
supernatants were determined as described [25]. By adding
Ringer’s solution, the phospholipid concentration of the LA
suspension was adjusted to 1 mg/ml. Surface activity of BALF was
measured with a pulsating bubble surfactometer (Electronetics,
Buffalo, NY) [26]. For the pulsating bubble surfactometer, 40 mlo f
the LA suspension, which had been given a phospholipids
concentration of 1 mg/ml, were used for filling the sample
chamber with a micropipet. The surface tension used for statistical
analysis of this study was the value at minimal bubble size (cmin)
registered after 5 min of pulsation at a rate of 20 cycles/min and at
a temperature of 37uC. Before starting, bubble pulsation
adsorption rate was evaluated by determining surface tension 10
s after formation of a bubble (cads).
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